Research in Aplastic Anemia, Myelodysplastic Syndromes MDS - LOI

Sponsor Deadline: 

Feb 15, 2018

Letter of Intent Deadline: 

Feb 15, 2018

Sponsor: 

Aplastic Anemia and MDS International Foundation

UI Contact: 

AA - MDS Foundation  http://www.aamds.org/professionals/fund-your-research

PDF guidelines  https://www.aamds.org/sites/default/files/2018%20RFP%20AAMDS%20Final_1.pdf

The Aplastic Anemia and MDS International Foundation, Inc. (AAMDSIF) is pleased to help researchers dedicated to the study of bone marrow disorders, advance the understanding, prevention and treatment of the following bone marrow disorders:
• Aplastic Anemia (focus on acquired)
• Myelodysplastic Syndromes (MDS) - MDS transition to Acute Myeloid Leukemia (AML)
• Overlap between Myelodysplastic Syndromes and Myeloproliferative Neoplasms (MDS/MPN) - Includes Chronic Myelomonocytic Leukemia (CMML)
• Paroxysmal Nocturnal Hemoglobinuria (PNH)
• Pure Red Cell Aplasia (PRCA)

Grants in the amount of $60,000 over two years (30K each year) will be awarded to eligible national and international researchers, for qualified projects.

Categories: 

Keywords: